Design Therapeutics Finds $45M
socalTECH
MARCH 24, 2020
San Diego-based Design Therapeutics , which is developing therapies for patients with serious degenerative disorders caused by nucleotide repeat expansions, has raised $45M in a Series A financing round. The round was led by SR One, and also included Cormorant Asset Management, Quan Capital and WestRiver Group. and Aseem Ansari, Ph.D.
Let's personalize your content